Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative
- Conditions
- Type 2 DiabetesHypertensionHyperlipidemiaHealth-related Social Problems
- Registration Number
- NCT06831162
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
The goal of this study is to evaluate the effectiveness of a multi-level health-related social needs (HRSN) initiative among adult patients diagnosed with type 2 diabetes, plus hypertension or hyperlipidemia. The multi-level initiative includes HRSN data collection, training and tools for health care professionals, care coordinator support, and community resources. Patients with type 2 diabetes plus hypertension or hyperlipidemia will be screened for HRSN as part of the primary care clinic intake process to assess if patients have any social needs (like difficulty with getting food, housing, or transportation). If patients screen positive for having social needs, then patients will be offered support, which can include help from primary care providers with adjusting a patient's disease management plan, referrals to care coordinators to provide additional assistance in addressing social needs, and information about community organizations that offer resources for social needs. The initiative will be integrated as a system change across VUMC adult primary care practices.
The investigators will use a prospective, single-arm clinical trial to evaluate effects on clinical outcomes for 12 months. Data will be extracted from the EHR on adult patients diagnosed with type 2 diabetes, and either hypertension or hyperlipidemia. The investigators hypothesize that the initiative will reduce the impact of HRSN on clinical outcomes over the study period. The investigators will also administer surveys to a subgroup of patients to examine trends in self-reported psychosocial and behavioral measures over the course of the initiative.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 4809
- 18 years of age or older
- Completed the health-related social needs (HRSN) screener as part of a primary care visit
- Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
ELIGIBILITY CRITERIA FOR PATIENT SURVEYS (subset of EHR data)
Inclusion Criteria:
- 18 years of age or older
- Completed the HRSN screener as part of a primary care visit
- Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
- English-speaking
- Blindness
- Hearing impairment
- Conditions that would interfere with survey completion (e.g., significant dementia, active psychosis or mania)
- Being near the end of life (hospice or home hospice)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in glycemic control Baseline and 12 months post-baseline Hemoglobin A1c extracted from the electronic health record where higher values indicate worse glycemic control.
- Secondary Outcome Measures
Name Time Method Change in cholesterol Baseline and 12 months post-baseline Low-density lipoprotein (LDL) extracted from the electronic health record where higher values indicate worse hyperlipidemia.
Change in blood pressure Baseline and 12 months post-baseline Systolic blood pressure extracted from the EHR where higher values indicate worse hypertension.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States